2 results
Approved WMOCompleted
Does oral simvastatin at standard doses alter BMP pathway signalling in colorectal cancer specimens in humans?
Approved WMORecruiting
To evaluate whether a faecal calprotectin guided strategy of anti-TNF dosing interval lengthening is non-inferior in maintaining remission in patients with IBD compared with an unchanged dosing interval.